Comparative Study of Bacille Calmette Guerin (BCG) Delivery Via Disposable Syringe Jet Injector and Needle & Syringe

NACompletedINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Tuberculosis
Interventions
DEVICE

Bioject ID Pen

Participants in this arm will receive a standard dose of BCG via the Bioject ID needle-free jet injector device (investigational administration technique).

DEVICE

Needle and syringe

Participants in this arm will receive a standard dose of BCG via syringe and needle by the Mantoux technique (standard of care administration technique).

Trial Locations (1)

7925

SATVI, University of Cape Town, Cape Town

All Listed Sponsors
collaborator

World Health Organization

OTHER

collaborator

University of Cape Town

OTHER

lead

PATH

OTHER

NCT01742364 - Comparative Study of Bacille Calmette Guerin (BCG) Delivery Via Disposable Syringe Jet Injector and Needle & Syringe | Biotech Hunter | Biotech Hunter